Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine

Multiple Sclerosis (MS) is a chronic inflammatory, immune-mediated, demyelinating disorder of the central nervous system with a heterogeneous clinical presentation and pathology in which activated lymphocytes play an important role in mediating tissue damage. Until recently, all first line therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiner, Teri L., Miravalle, Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619698/
https://www.ncbi.nlm.nih.gov/pubmed/23650463
http://dx.doi.org/10.4137/JCNSD.S5128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619698/
https://www.ncbi.nlm.nih.gov/pubmed/23650463
http://dx.doi.org/10.4137/JCNSD.S5128

Ejemplares similares